A detailed history of Kestra Advisory Services, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 15,500 shares of LXRX stock, worth $11,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,500
Previous 15,500 -0.0%
Holding current value
$11,780
Previous $26,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $1,540 - $2,280
1,000 Added 6.9%
15,500 $26,000
Q1 2024

May 15, 2024

BUY
$1.3 - $3.58 $18,850 - $51,910
14,500 New
14,500 $34,000
Q2 2023

Aug 11, 2023

BUY
$2.15 - $3.49 $30,652 - $49,756
14,257 New
14,257 $32,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $143M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.